Protagonist Therapeutics Inc (PTGX)
Capital Expenditure
-$168.00K
Quarterly · Period ending: · USD
PTGX Capital Expenditure
Latest reported-$168.00Kperiod ending
Latest reported-$168.00Kperiod ending
PTGX Quarterly CapEx (-$5.00K → -$168.00K)
Quarterly CapEx
High-resolution chart · PNG
PTGX capital expenditure history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Capital Expenditure (USD) |
|---|---|
| -168,000 | |
| -215,000 | |
| 1,446,000 | |
| -88,000 | |
| -813,000 | |
| -545,000 | |
| -310,000 | |
| -775,000 | |
| -28,000 | |
| -242,000 | |
| -19,000 | |
| -404,000 | |
| -176,000 | |
| -10,000 | |
| -70,000 | |
| -162,000 | |
| -290,000 | |
| -273,000 | |
| -196,000 | |
| -265,000 | |
| -500,000 | |
| -140,000 | |
| -125,000 | |
| -75,000 | |
| -133,000 | |
| -138,000 | |
| -218,000 | |
| 309,000 | |
| -892,000 | |
| -166,000 | |
| -62,000 | |
| -148,000 | |
| -68,000 | |
| -208,000 | |
| -56,000 | |
| -190,000 | |
| -372,000 | |
| -48,000 | |
| -52,000 | |
| -48,000 | |
| -28,000 | |
| -251,000 | |
| -220,000 | |
| -113,000 | |
| -61,000 | |
| -5,000 |